Long-term results of maintenance treatment of mitomycin C or alternating mitomycin C and bacillus Calmette-Guerin instillation therapy of patients with carcinoma in situ of the bladder: A subgroup analysis of the prospective FinnBladder 2 study with a 17-year follow-up

Riikka Järvinen , Eero Kaasinen, Erkki Rintala, Finnbladder Grp

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Originalspråkengelska
TidskriftScandinavian Journal of Urology and Nephrology
Volym46
Utgåva6
Sidor (från-till)411-417
Antal sidor7
ISSN0036-5599
DOI
StatusPublicerad - dec 2012
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 3121 Inre medicin

Citera det här

@article{ec70d902587e4388b062097b4305952e,
title = "Long-term results of maintenance treatment of mitomycin C or alternating mitomycin C and bacillus Calmette-Guerin instillation therapy of patients with carcinoma in situ of the bladder: A subgroup analysis of the prospective FinnBladder 2 study with a 17-year follow-up",
keywords = "alternating therapy, bladder cancer, chemotherapy, immunotherapy, intravesical, non-muscle-invasive, RANDOMIZED CLINICAL-TRIALS, URINARY-BLADDER, INTRAVESICAL INSTILLATION, UROTHELIAL CARCINOMA, COMPETING RISK, EAU GUIDELINES, CANCER, METAANALYSIS, PROGRESSION, TUMORS, 3121 Internal medicine",
author = "Riikka J{\"a}rvinen and Eero Kaasinen and Erkki Rintala and {Finnbladder Grp}",
year = "2012",
month = "12",
doi = "10.3109/00365599.2012.694906",
language = "English",
volume = "46",
pages = "411--417",
journal = "Scandinavian Journal of Urology and Nephrology",
issn = "0036-5599",
publisher = "Informa healthcare",
number = "6",

}

TY - JOUR

T1 - Long-term results of maintenance treatment of mitomycin C or alternating mitomycin C and bacillus Calmette-Guerin instillation therapy of patients with carcinoma in situ of the bladder: A subgroup analysis of the prospective FinnBladder 2 study with a 17-year follow-up

AU - Järvinen , Riikka

AU - Kaasinen, Eero

AU - Rintala, Erkki

AU - Finnbladder Grp

PY - 2012/12

Y1 - 2012/12

KW - alternating therapy

KW - bladder cancer

KW - chemotherapy

KW - immunotherapy

KW - intravesical

KW - non-muscle-invasive

KW - RANDOMIZED CLINICAL-TRIALS

KW - URINARY-BLADDER

KW - INTRAVESICAL INSTILLATION

KW - UROTHELIAL CARCINOMA

KW - COMPETING RISK

KW - EAU GUIDELINES

KW - CANCER

KW - METAANALYSIS

KW - PROGRESSION

KW - TUMORS

KW - 3121 Internal medicine

U2 - 10.3109/00365599.2012.694906

DO - 10.3109/00365599.2012.694906

M3 - Article

VL - 46

SP - 411

EP - 417

JO - Scandinavian Journal of Urology and Nephrology

JF - Scandinavian Journal of Urology and Nephrology

SN - 0036-5599

IS - 6

ER -